GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Cash, Cash Equivalents, Marketable Securities

CryoPort (CryoPort) Cash, Cash Equivalents, Marketable Securities : $448.5 Mil (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is CryoPort Cash, Cash Equivalents, Marketable Securities?

CryoPort's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 ($465.86 Mil) to Dec. 2023 ($456.76 Mil) but then stayed the same from Dec. 2023 ($456.76 Mil) to Mar. 2024 ($448.54 Mil).

CryoPort's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($628.80 Mil) to Dec. 2022 ($523.32 Mil) and declined from Dec. 2022 ($523.32 Mil) to Dec. 2023 ($456.76 Mil).


CryoPort Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for CryoPort's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort Cash, Cash Equivalents, Marketable Securities Chart

CryoPort Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.30 93.32 628.80 523.32 456.76

CryoPort Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 522.61 504.67 465.86 456.76 448.54

CryoPort Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


CryoPort  (NAS:CYRX) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


CryoPort Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of CryoPort's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


CryoPort (CryoPort) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Executives
Robert J Hariri director 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton director, officer: President, CEO C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman director 305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich officer: Chief Financial Officer
Mark W Sawicki officer: Chief Scientific Officer 3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p. 10 percent owner C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock director 7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini director 20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam director 4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath director C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman 10 percent owner C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154